<SEC-DOCUMENT>0001615219-21-000020.txt : 20210303
<SEC-HEADER>0001615219-21-000020.hdr.sgml : 20210303
<ACCEPTANCE-DATETIME>20210303162339
ACCESSION NUMBER:		0001615219-21-000020
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210303
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210303
DATE AS OF CHANGE:		20210303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salarius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001615219
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				465087339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36812
		FILM NUMBER:		21709274

	BUSINESS ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021
		BUSINESS PHONE:		346-772-0346

	MAIL ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Flex Pharma, Inc.
		DATE OF NAME CHANGE:	20140730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>salarius2021cmpo-form8xkla.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7f27125d43f74e90829071c0e09efb39_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">United States</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM 8-K</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 3, 2021</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Salarius Pharmaceuticals, Inc.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delaware</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">001-36812</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Commission File Number)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46-5087339</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(I.R.S. Employer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Identification No.)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2450 Holcombe Blvd.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Suite X</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Houston, TX &#160;&#160;&#160;&#160;77021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Address of principal executive offices)&#160;&#160;&#160;&#160;(Zip Code)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(832) 834-6992 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number,including area code)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N&#47;A</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">see</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:13.7pt;text-align:justify;text-indent:-13.7pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div><div style="margin-bottom:3pt;padding-left:13.7pt;text-align:justify;text-indent:-13.7pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="margin-bottom:3pt;padding-left:13.7pt;text-align:justify;text-indent:-13.7pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="padding-left:13.7pt;text-align:justify;text-indent:-13.7pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))</font></div><div style="padding-left:13.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:35.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.116%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center;text-indent:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Title of each class</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Trading symbol(s)&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5pt;padding-right:5pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Stock, par value $0.0001 per share</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SLRX</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Nasdaq Capital Market</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b&#8211;2 of the Securities Exchange Act of 1934 (&#167;240.12b&#8211;2 of this chapter). Emerging growth company   </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01 Regulation FD Disclosure.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, on February 5, 2021, the Company entered into an At The Market Offering Agreement, dated as of February 5, 2021, with Ladenburg Thalmann &#38; Co. Inc. to offer and sell shares of its common stock having an aggregate offering price of up to $6,306,000 from time to time.  From February 5, 2021 through the date of this report, the Company sold an aggregate of 2,820,493 shares of its common stock at an average sales price of $2.24 per share. As of February 28, 2021, 27,854,867 shares of the Company&#8217;s common stock were outstanding.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the period between September 30, 2020 and February 28, 2021, the Company has issued an aggregate of 5,190,508 shares of common stock in connection with the exercise of outstanding warrants and received aggregate proceeds of $4,642,655 in connection with such warrant exercises. As of February 28, 2021, the Company had  7,820,326 warrants outstanding with a weighted average exercise price of $1.16, 1,563,972 options outstanding with a weighted average exercise price of $2.44 and $17.4 million in cash and cash equivalents on hand.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.2, shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act, except as shall be expressly set forth by specific reference in such filing.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 &#160;&#160;&#160;&#160;Other Events.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2021, the Company announced that it has commenced an underwritten public offering of its common stock. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 &#160;&#160;&#160;&#160;Financial Statements and Exhibits.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:6.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">99.1&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline"><a href="salarius2021cmpolaunchrele.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline">Press Release dated March 3, 2021.</a></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SALARIUS PHARMACEUTICALS, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; March 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; David J. Arthur</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David J. Arthur</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>salarius2021cmpolaunchrele.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7535efe4e98d4767ae7d497036572572_1"></div><div style="min-height:72pt;width:100%"><div style="padding-right:22pt"><img alt="image_01a.jpg" src="image_01a.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:198px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Salarius Announces Proposed Public Offering of Common Stock</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">HOUSTON,&#160;March 3, 2021 (GLOBAL NEWSWIRE) &#8211; Salarius Pharmaceuticals, Inc. (Nasdaq&#58; SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ladenburg Thalmann &#38; Co. Inc. is acting as sole book-running manager in connection with the public offering.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A shelf registration statement on Form S-3 (File No. 333-231010) relating to the shares was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and was declared effective by the SEC on May 17, 2019. A copy of the preliminary prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained be obtained at the SEC&#8217;s website at www.sec.gov or from Ladenburg Thalmann &#38; Co. Inc., Attn&#58; Prospectus Department, 640 Fifth Avenue, New York, NY 10019 or by email at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">prospectus&#64;ladenburg.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About&#160;Salarius Pharmaceuticals, Inc.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius&#8217; lead candidate, seclidemstat, is being studied as a potential treatment for pediatric cancers, solid tumors and other cancers with limited treatment options. Seclidemstat is currently in a Phase 1&#47;2 clinical trial for relapsed&#47;refractory Ewing sarcoma, for which it has received Fast Track Designation, Orphan Drug Designation and Rare Pediatric Disease Designation from the U.S. Food and Drug Administration. Salarius is also developing seclidemstat for several cancers with high unmet medical need, with a second clinical study in advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also the recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">salariuspharma.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward-Looking Statements</font></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This press release contains forward-looking statements within the Private Securities Litigation Reform Act of 1995, including statements that relate to the offering, the expected completion of the offering, and other information that is not historical information. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include risks and uncertainties related to completion of the public offering on the anticipated terms or at all, market conditions, the impact of the COVID-19 pandemic, and the satisfaction of customary closing conditions related to the public offering. More information about the risks and uncertainties faced by Salarius is contained in the sections captioned &#8220;Risk Factors&#8221; in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4842-9272-4702.v4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">preliminary prospectus supplement and the accompanying prospectus related to the public offering filed with the SEC, including the documents incorporated by reference therein. Salarius disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.</font></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contact</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tiberend Strategic Advisors, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Maureen McEnroe, CFA&#47;Miriam Weber Miller (investors)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(212)&#160;375-2664&#47; 2694</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">mmcenroe&#64;tiberend.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">mmiller&#64;tiberend.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Johanna Bennett (media)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(212)&#160;375-2686</font></div><div style="margin-bottom:8pt"><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">jbennett&#64;tiberend.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4842-9272-4702.v4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" #C <P# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCU=HM.U_>\G\_(NB\9@<0H2U3^?W>A_4M"^]-V:=5?3#.;&(W,:K(8U+*IR
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MOK;1IF,:N,P->,:DKI^=_P S^MGQ%.T>CSW$+;9(X7>-BN<$*<'\\5_.3/\
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MK:+'?*\"VK2 *KD;3N'4=:^>_P#@B#_P5P_;F_;>_;>F^"7[1/CO0-2\/Q^
M]1U6.WTOPO#92"ZAN+-(VWH2< 3/QWS74?\ !UH"O[,WPK!_Z'RX_'_09*^0
M_P#@V+_Y2;W/_9*=8_\ 2S3:XL#@,#4X1G7E3BYI2ULK[]]S2K6JK-(P4G;3
M3IL?K?\ \%E_VH?C+^QW^PAXB^/?P%UBRL?$VEZOIEO9W&H:>MU$JS7<<4@,
M;<'*,0/0\U^:W_!-S_@N!_P47_:6_;U^%OP(^+OQ#\,WGAKQ-X@EM-8M;+PA
M!;RR1K97$P"R*V4.^-#P.U?='_!QI_RBN\9?]C%HG_IPAK\8_P#@C#_RE5^!
MO_8W7'_IMO*,CR_!8CANO5JTXN2Y[-I75HJVN^CU'BJM2.80BI.SMI\S^HCG
MR\'TK\Q?^#@#_@I/^UQ^P#XT^%^E_LQ>+=%TN'Q78ZS-K2ZQX?COO,:V>S$1
M7>PV8$SYQUS[5^G1^Y7XG?\ !V=_R43X%_\ 8'\2?^C=-KP>&Z%'$9Q3IU8J
M47S:-77PL[,=.4,)*479Z?FCV?\ X(#_ /!3C]L7]O7XS>/O"G[3'C'1-2L?
M#_ANTO=-CTOPY%9,DTEPT;%F1CN&U0,&OTK^*/Q#\&_"CP-JGQ(^(/B*UTG1
M=$TZ>]U34KU]L-M;QH6>1SV  _'IWK\6/^#4,X_:)^+/_8EZ?_Z5O7TE_P '
M17QI\6> OV)_#/PL\.:E);V_CKQS%;:YY;$&>RM87N?*/^R9UMR1W"XZ9KT,
MVRNC6XF6#H)0C+EV5DM$V[?>8X7$2CE_M9.[5SX]_;K_ .#DS]I[XL>,[SPQ
M^QA';^ ?!UO(T5MKEY8QW.LZFH;B;]Z#':1G'$81GYY<$;:^9]-_X+&_\%1=
M,O?[0B_;3\72.#NVW*V\R$Y[HT17] /I6S_P1I_8=^&7[>_[8<?PG^,>JWD/
MAS2/#=UK>H6-E=&&?4?*EAA2W60?,@)FW,5PVU< C)K]D_B1_P &^G_!+3Q]
MX*D\,:!^SK%X4O?+Q;:]X;UFZCNX6 X;+R,L@SV=2#7T6*Q7#7#]9826'OHF
MWRQ>_=O5LX:=/'8R+J*=NVK1\B?\$SO^#D;QGXC\=:=\$_V_;'18X-5NH[72
M_B5I=O\ 8X[:5VP%OX<E%0DJ//0J%)&]<?,/V9L;N"\B\ZVE#HP!5EZ'CK7X
MT_LB_P#!L;'HG[1FLZG^UQXRL?$/P]T/5 /#.C:?(T<GB> A6#7P!!@B&[8\
M2G,A4G(4X/[(:)H>G>'M/ATG2+..WM;>%(K>WA7:D4:J%55'8   #H *^/XA
M>32Q:>7;-7E;X;Z6MUO;=;(]3!?6E3M7^1<HHHKP3L"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!'7>NTFO"/V_OV-/"_P"V5\!K[X=WLD=KK=F#=^&=
M7D7)L[Q0<9/4QN,HZ]PV>H!'O%->-)/OKFNC"8K$8'%0Q%"7+.#33[-?UKW1
MRX[ X7,L'/"XB*E":LT^J?\ 6G8_F.^*O@[QA\)O&^K?#GQ_HDVG:QHMZUKJ
M%C.I#12+W]"I&"K#A@01D&N(U#4"&QNK]O/^"OW_  3!M/VK_!<_QL^#6CQI
M\2=!T_Y;6%0O_"06R9(M7)( E4;O+<]_D/!!'X9^)8=0T;4KC2=5L)K6YM;A
MX+BWN(V22*1&*LCJ>58$$$=C7]0<-\68;B3+U5C95(Z3CV?=?W7T?RZ'\C\3
M\$XOA7-'3:;I2UA+NNS[275?,ZOX&?M%_%;]F3XKZ;\9/@OXFDTK6M,DRK+\
MT-S%QYD$R'AXG489>#W!5@&'[M_L@_\ !5GX#_M.?LS:E\:Y=0@T?5/#-F&\
M9>&9KC?/8SG.P1=/-BE;B-P.<X.&!%?SOW$S.RQQ(69CA5"Y+'I@#N?0>M?4
M'[,GP9F^&GAU_$?B%#'K6K0J)X%<@6L(8,(\#@MG#'T/3O7'G?!^!XLKTW/W
M91:O);\O6+[WZ=GKW1>'\2,5X=Y34DO?YTU"#?V[:2MV6\MDUI>]CW[X\?&;
MQ+\?OBMJWQ1\3R;9M1FQ;VZL2MO;CB.%<D\*OYDD]Z^^_P#@CCG_ (9SU@'_
M *&Z?_TGMZ_-4?>#*G?MWK]./^"0^BSZ9^RY)JLJL%U+Q)=S1[OX@JQQ9_[Z
MC8?A4^*5'"X'@J.&I+EBIPC%>23LON1\7]'_ !6.S;Q6GC<1)SG*G5G.3W;D
MXW?WL^K:CGMTG #D\>E*[%8MV:^>_P!L;_@IS^Q]^PSHTUU\>/B_:V^J^3YE
MEX6TN/[7JMYQD".W0Y7/]Z0H@[D#FOYIHT:V(J*G2BY-]$KL_O*4HP5Y.QM_
MM9_\$]OV2?VV=$71OVBO@_INN26\+)8ZHNZWO[/KS%<1%9%QZ9(]J_-G]H__
M (-4=!\^XUC]DK]IV^L5;+0^'_'NFB[11@D*MW;;''/'SQN?4U]O?\$P?^"J
M_P +_P#@IQX7\6:OX0\.3^&=4\+ZY]GF\,ZE>)->'3Y(T:VO6V#8!(PG0JI;
M8T1!)RI/UD(8]O*^]>I2S'.LDK.A&;AR[Q>J[[._X'-*CA<9'F:OYG\J_P"V
ME_P3+_;'_8*DAO/C_P##%DT.ZN%@M?%6B3?:M-DE;[L;2@ Q.QZ+(%+=!DCG
M@?V6/VE/'G[(/[0/A?\ :-^',L@U+PQJ2SSVJN0M]9Y N+1P"-R2Q;DP> 2&
MZ@$?U0?M5?"OX<_&+]GWQI\-OBGHUO?:!JWARZ@U*&ZC#(D9B8[^>A0@.&_A
M9 1@@&OY'(,26BE_F/E#=[\=?YU^B\/YO+/L+4AB8*ZT=MFGY/9[WZ=CP\;A
M5@JD94WY_<?V(^"?$>C>-O!FE^,=%N?.L=5TZ"[M6SD/%+&KH??*D?6OEG]O
M?_@L?^Q__P $_P#4?^$&^(VK76O>,FMEG'@_PW&LUU#&PRCSL2$MPPY&\@D<
M@8P:DM/VAK[]E#_@B]X?_:+6TCN-2\+? 70[NTM;MOEEOSIEM' C^QF>,'V-
M?S@Z'I/Q;_:G^.]KHD%U-XB\>?$/Q2J&XNI/WFHZE=R@&21NBKDY)Z)&O PH
M6OCLAX>P^85*M3$/]U3;79NWGT26K_ ]3&8Z6'C&,%>4C]<'_P"#L[PI#+(E
ME^P]K4L6[]W)-XTMU9AZD" @$^@)KY#_ ."M'_!8O3_^"G_@+P9X)LO@!>>#
M?^$3\0W&I_:KC7H[T7/F6S0^6 L:%"-V[/(/2OJ/P5_P:<ZC-X<M9/'_ .VE
MLU5H5-W%H?A)7M8WQRL;32AV4>I"YZX%?+?_  5E_P"".^C?\$P? ?@[QK8_
M'>]\7R>+O$$^G?9;O18K7[.L5N9C("CMNR0%VG&,U]#EKX/^OTU@_P")?W?C
M[/OIL<.(_M3V,O:VMUV/1_\ @USS_P / O$PS_S2N]_]..G5^@7_  <J$_\
M#J_Q$/\ J;M _P#2^*OS]_X-<_\ E(%XF_[)7??^G'3J_0+_ (.5/^46'B+_
M +'#0/\ TX15YF<?\EI1]:?YHZ,+_P BF7I(_(?_ ((<?\I6?@]_V&+W_P!-
MMW7].;<P]>U?S&?\$.?^4JOP?/\ U&KS_P!-MW7].4A MR2?X:PXX_Y&5/\
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MO@#1S_Y)0UZ)7P>(DYXB<GNY-O[SVJ>E-)'Y/_\ !UO_ ,FS_"O_ +'RX_\
M2*2OD/\ X-B_^4F]S_V2G6/_ $LTVOKS_@ZW_P"3:/A7_P!C[<?^D4M?(?\
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M1RP^:NUL$;LU)10!!]B7' 'YGBGK$RC&[\<U)118"-H26W9'XTXJQ3;FG44
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MVNOV67&5_:%\%_\ A16__P 71)^US^RXG3]H'P6W^[XBMO\ XNO&_M2M%?\
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M_P"R1\+?A]^V+^T=\7?VA/B?X;LO$.D_V]'I/AR"_@$D(BB4C> W0^6D./\
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MXI2Z6OL>QA>(*/$64YA/#Q_=TG4IQFG=5.6"YI1TV4FXW3:;B]>WY]?L/?L
M>(_VA_V?=/\ B5IO[1OBCPW'<7EQ#_9>F3.(4\N0KN $BCYNIXKZ:_9K_P""
M?7B7]G_XLVGQ%U']HKQ1XECM[::+^S=3F<PMO7;DYE;D=1Q7%_\ !+;]HGX&
M_#7]D;1_"WC[XL>']'U"/4[YY+/4-5BAD53.2"59@<$<]*^CH_VP_P!ER:58
M(/C[X4D>1@JJFN0DDD\#[U?7\49QQ54S/&82',Z+G.*2IIWC?^91OMUO?S/S
M_@#AWP_HY!EV/J2A'$*G3FVZS5I\J;O%SMH^EK=+'HEU^[L'#'I$1^E?(_\
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MWBU;PO\ $C3?MJR0V\L:KJ$2"5UVR*IS@7)SCG>,9Q7WR^39<_\ /,5\(_\
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MU)$I2,(>U<W\8/A3X2^-WP\U#X8>.K>:72=45%O(X)C&S!75QAAR.5%?/_\
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MMJ[)^BO;\V,EVA>?6O@+_@LU_P %5++]CCP/_P *,^#>LPR?$_Q#:DB3[_\
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M,?Y8_P";ZL_ISA7AO!\,97'#4=9/64NLI?Y+9+L!4$8Q67JW@OPAK\L<^O\
MA73;YXE(C:\L8Y"@/7&X''0?E6I4<]S!;!3/*J[CA=W>O"C*4)7B['T<X0J1
MY9I-=GJ8O_"K/AC_ -$YT'_P3P__ !-'_"K/AC_T3C0?_!/!_P#$UK+JNFN<
M+>QG/3#=:%U33GD6)+V-F9<JJMDD>OT]ZT^L8C^=_>S#ZG@_^?<?N7^1D_\
M"J_AA_T3?0?_  3P?_$T?\*K^&!Z_#C0?_!/!_\ $UNJZLNY3Q2[AZT?6,1_
M._O8_J>#_P"?<?N7^1@_\*K^& Z?#C0?_!/!_P#$T?\ "K/AC_T3C0?_  3P
M?_$UN//%&,O)CZU2N/%'AJTU&'1[K7[..\N0QMK62X422@#)*J3EL#DX' H^
ML8CI)_>Q?4\'_P ^X_<O\BA_PJSX8_\ 1.-!_P#!/!_\31_PJOX8'K\.-!_\
M$\'_ ,36XLT3_=<<<4[<OK1]8Q'\[^]A]3P?_/N/W+_(P?\ A5?PP'3X<:#_
M .">#_XFC_A5GPQ_Z)QH/_@G@_\ B:WMR^M&1ZT?6,1_._O8_J>#_P"?<?N7
M^1@_\*L^&/\ T3C0?_!/!_\ $T?\*K^&'_1-]!_\$\'_ ,36]D4;AZT?6,1_
M._O8?4\'_P ^X_<O\C!_X59\,?\ HG&@_P#@G@_^)H_X59\,?^B<:#_X)X/_
M (FM[(]:CDNH(E9Y90H7[Q;M_G%'UC$?SO[V'U/"?\^X_<O\C%_X57\,#U^'
M&@_^">#_ .)H_P"%6?##_HG&@_\ @G@_^)K7_M/3NU['_P!]5)%<03QK+#*K
M*PRK*>#1]8Q'\[^]D_4\'_S[C]R_R,3_ (57\,#U^'&@_P#@G@_^)H_X57\,
M.G_"N-!_\$\'_P 36Y)-%$N^20 4V&ZM[E/,MYE=>S*V0:/K&(_G?WL?U/!_
M\^X_<O\ (Q?^%5_"_P#Z)OH/_@G@_P#B:/\ A5?PP'3X<:#_ .">#_XFMXL
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MG&@_^">#_P")H_X57\,!T^'&@_\ @G@_^)K>S37D5!EC1]8Q'\[^]C^IX/\
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M3).MCN3*R:?_ *0Q /\ $C/O[$,V<@G/?>,?V1?V_OVJ_P!D3X5?"O6OB/\
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MK] OVT='_817X5_!%OV@[R2QTFS^*'AD_"=_#*S*QUSD:='&;92WV9AD./\
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MC!X^LKF);5=LEO#"4BB8 8V*N0%Z#)]:\,^%UMX0U+]E?_@F'%\1/LLVEO\
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MN9J/WI7]&C:C5=:/-_7G^(ZBBBO+-@HHHH **** "BBB@ KP_P#X*6SS6O\
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MC^#%C^TIX/\ VHM+CU*SUSP/X'F\)Z%86UYBRBTV1@Q1HR,EAM #9X I+/\
M8C^#=K\>_B9^T!?1ZC?:E\5O#=CH7C#2[VZ$EC/8VL+PHBQ;?EW1RNK'/(8\
M=Z]H,<9ZQK^5+L7^Z/RK@^L8C;F>UM^E[V^_7U->6/8^%OA__P $$OV0?!'C
M#0KZX^(OQ0UKPGX7UZ/5_#GPUUSQI)/H&GW<;F2(I!M#$(YR SD UZ+^U;_P
M2J_9_P#VKOCGH?[1VM>.O''A+QAHNEIIDVK>!_$K:>^I6*3&9;:YVJ=Z!V?I
MM)#D$X KZD*(>J#\J-JGJHK:699A*HJCJ/F2:OY/?[^O<B-&BE;E1X)HO_!/
M']G/2I?C,-6T:^UBQ^/&HK>>/=+U:Z$UO*P@\G;" H,2E3G@Y# $'(%>5_L_
M?\$3/V8_@/\ %CPQ\5)/B;\2O&0\",[> _#_ (W\7&_TWP[(1M$EM"8Q\R+@
M*7+;<#'2OM#:,8VTFQ/[@_*E''XV,7&-1V:L]=]+?EIZ:;#=&FVG9:'Q#\1O
M^"%G[+GCOQ;XHU32_B_\6O#/AOQMJ\VH>+_ /AOQS+!HNJSS/NG,D+*S*)3]
MX*Z@Y]*^O_AW\-_!WPN\#:3\-? 6AP:;HFA:;#8:5I]J-L=M;Q($CC4>R@#/
M4]36_L3^X/RI0 .@J*V+Q6(IJ%6;DEM?^OQ*C3C!W2/CO]J;_@B[^RO^TU\:
MKO\ :*LO&'C[X<^--0A\G7-<^&OB8Z;)JJ@;<W V,KMM !; ) &<FNX_9T_X
M)D_LD?LS_LX^(?V8? _@%KWPYXNAG7QE)KUP;NZUYIHS%(]S*W+,4.!C 7J,
M'FOHS:/[M($4=%'Y54L?CIT52E4DXJUE?MM]W3L3[&ES7Y5<^*/@A_P0X_98
M^#'Q-\+_ !#E^)'Q*\767@6^^V>!?"/C+Q>U]I&@W /[N2"#8OS1_P &\MMP
M".@KZ!^''[*/PX^&'[1WQ#_:@\-76J2>)/B=#I,/B1;N[#6RKIUN;>W\J/ \
MOY&.[DY/->K;%_NC\J B#H@_*BMCL9B+NK4<KJVKZ7O;[TGZZA&G3ALCQ3X*
M_L2_"+X$?#CXA?#+P5?ZS)I_Q*\3:QKOB"2]OQ)*MUJ2[;CRFV@(O]T8X]Z^
M)_V]?V#?@QX&F_8G_83T_2=9U3P'8?$/5-)8WEW(UTELVF3N)&N(E!C=9&5D
M<8PP4]J_4+RXQP(U_P"^:AFTVQGF6:>UC=D_U>Y =OT]*TP^8XK#UO:<S>_7
MJXN-_5)BJ48SCR_UO<^8?V2O^"5?P!_9/^)>M?&^/QMXV\?>,-=T4:1+XF^)
M&NC4[FVT[*L;2+**$C8JN[@E@,$GFO+V_P"#?C]CRZ\/:K\-KGXE_%23P+?M
M=2Z;\.V\;/\ V-H\\V3YUM"$!W1LQ9 [.JGG&0#7WHL:*,!*78F,;!^5*.99
MA&HYJK*[MU[;?=K:UK7#V-*UN5?\.>(>$/V&O@]X5^.G@G]HC3]0UM]=\!_#
M<^"-$6:^#0OII:-MTJ;1OFS&OS@COQ6'\0O!?[.?[#?C'XL?\%#O'&MZU;-X
MMT_1U\:2>6]W##%9#[-;-#;Q(7'^MPV,YSGM7T6$4# 4?E3+BTM;J$P7-LDB
M-]Y&4$'\ZP^L5I2]^3:M9Z[QNG;[U?UU+Y(K9'Y^_P#!'/X>6'Q8^-G[0/\
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 52UY$?39MZ!L)G:PR/RHHIQ^(">R 6%5 _AJ:BBD
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
